Secondary Logo

Journal Logo

October 2009 - Volume 104 - ACG Annual Meeting Abstracts Supplement 2009
pp: S1-S576

ESOPHAGUS


Randomized Open-Label Trial to Assess the Impact of Dosage Timing of Omeprazole/Sodium Bicarbonate (Zegerid 40 mg) on Healing of Severe Reflux Esophagitis: Preliminary Results: 20

Francis, Dawn; Dabade, Tushar; Abdalla, Adil; More

American Journal of Gastroenterology. 104:S8, October 2009.

Should Patients with Severe Reflux Esophagitis Undergo Repeat Endoscopy After 8 to 12 Weeks of Proton Pump Inhibitor (PPI) Therapy to Exclude Underlying Barrett's Esophagus (BE)? Preliminary Results from Two Prospective Trials: 27

Jung, Kee Wook; Francis, Dawn; Arora, Amindra; More

American Journal of Gastroenterology. 104:S10-S11, October 2009.

Secular Trends in the Epidemiology and Natural History of Barrett's Esophagus in Olmsted County, MN: A Population Based Cohort Study: 33

Prasad, Ganapathy; Wang, Kenneth; Romero, Yvonne; More

American Journal of Gastroenterology. 104:S13-S14, October 2009.

Predictors of Overall Survival in a Large Population Based Barrett's Esophagus Cohort: 2009 ACG/Governor's Award for Excellence in Clinical Research: 47

Prasad, Ganapathy; Wang, Kenneth; Romero, Yvonne; More

American Journal of Gastroenterology. 104:S19-S20, October 2009.

ESOPHAGUS: PDF Only


STOMACH


Show: